Apidra (insulin glulisine) is the newest rapid-acting insulin

Apidra (insulin glulisine) is the newest rapid-acting insulin.

But it's just a "me-too"...similar to Humalog (insulin lispro) and NovoRapid (insulin aspart).

Patients will inject Apidra around meals...from 15 minutes before eating up to 20 minutes after starting a meal.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote